Patrick Soon-Shiong

Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer. He has received US FDA approval for a new class of immunotherapy drug called Anktiva in non-muscle invasive bladder cancer in 2024. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. He is currently Executive Chairman, Global Chief Medical & Technology Officer at ImmunityBio. Dr. Soon-Shiong currently holds over 850 worldwide patents.

Soon-Shiong is the chairman of Chan Soon-Shiong Family Foundation, a non-profit foundation. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the ''Los Angeles Times''.

Soon-Shiong's net worth is US$12.0 billion as of 2025 according to Bloomberg Billionaires Index and Forbes. He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world. Provided by Wikipedia